Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

NCT03113643

Conditions
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

NCT06788756

Conditions
Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Bioresearch Partners Miami, Florida, United States
  • Augusta University - Georgia Cancer Center Augusta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Atlantic Health Morristown, New Jersey, United States
View all 25 locations
View Trial Details
Recruiting

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

NCT07011004

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

NCT02074839

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-AZ Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California-Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions